Moneycontrol
    Moneycontrol PRO

    Business

    Jump to

    • Manpower and toll plaza management services provider Innovision files RHP to launch IPO on March 10

      Innovision IPO | The company will issue fresh shares worth Rs 255 crore, while promoters Lt Col Randeep Hundal, and Uday Pal Singh will offload 12.38 lakh shares via offer-for-sale.

    • Rajputana Stainless IPO to hit Dalal Street on March 9, price band set at Rs 116-122 per share

      Rajputana Stainless IPO | The comprises a fresh issue of 1.46 crore shares and an offer-for-sale of 62.5 lakh shares by promoter Shankarlal Deepchand Mehta.

    • Sedemac Mechatronics raises Rs 326 crore from 23 anchor investors; Rs 1,087-crore IPO to open on March 4

      Sedemac Mechatronics IPO | Xponentia-, 360 ONE-, and A91 Partners-backed company has finalised the allocation of 24.1 lakh shares to anchor investors at the upper end of the price band.

    • US-Iran escalation disrupts vital trade corridors, leaving Indian pharma on edge

      India exported $30.47 billion worth of pharmaceuticals in FY25, with around $1.75 billion tied to the Middle East and North Africa region, making the current situation particularly worrying

    • Artemis Medicare to raise Rs 700-crore through QIP to triple bed capacity

      The Gurugram-based healthcare provider, promoted by entities linked to the Apollo Tyres Group, aims to triple its total bed capacity to between 1,700 and 2,300 by 2029

    • ‘Pharma Has A Great Future in India Given Our Quality Of Talent & Our Low Manufacturing Cost’: Ajay Piramal

      Ajay Piramal India’s undoubted M&A stalwart speaks on “Latha & the Leaders” elucidating the mantra behind his M&A success. He also elaborates on the future of his group’s 2 major verticals -pharma & finance

    • IPO Action: Three new public issues to open for subscription next week with lined up of 9 listings

      Nine companies are scheduled for their markets debut next week including four firms - Clean Max Enviro Energy Solutions, Shree Ram Twistex, PNGS Reva Diamond Jewellery, and Omnitech Engineering - from the mainboard segment.

    • Rajeev Raghuvanshi gets one year extension as India’s top drug regulator

      The move comes as the government keeps regular recruitment rules for the post in abeyance, signaling a preference for leadership continuity within the Central Drugs Standard Control Organization (CDSCO) amid ongoing regulatory reforms.

    • XED to launch GIFT City's first IPO of $12 million; public issue to open on March 6

      XED Executive Development IPO | The public issue is open to eligible investors under the IFSCA framework, including Non-Resident Indians (NRIs), foreign portfolio investors, institutional investors, and other permitted overseas participants.

    • Carbon validation and verification provider Earthood Services withdraws IPO papers

      Earthood Services IPO | The public issue comprised entirely an offer-for-sale of 62.9 lakh shares, with no fresh issue component.

    • Abbott to distribute Novo Nordisk's semaglutide second brand Extensior in India

      The companies announced that Abbott will commercialise the drug in India while Novo Nordisk supplies the molecule, which is globally known as Ozempic.

    • FTA will be one of the biggest game changers: Santosh Iyer, MD and CEO, Mercedes-Benz India

      With clearer investment protection frameworks for European companies operating in India, the agreements could accelerate capital expenditure (capex) inflows and sustain growth momentum, Iyer said

    • The Reading List: February 27, 2026

      Our research and opinion teams have curated a selection of articles and social media gems from the world of economy, business and finance for your weekend read

    • GSK study flags low Shingles awareness among older Indians despite rising risk

      Shingles, caused by the reactivation of the varicella‑zoster virus (VZV), typically presents as a painful rash with blisters and can lead to long‑lasting nerve pain known as post‑herpetic neuralgia (PHN). Age‑related immune decline makes adults over 50—particularly those with chronic illnesses—significantly more vulnerable.

    • Control intensive products maker Sedemac Mechatronics to launch Rs 1,087 crore IPO on March 4, check price band and other details

      Sedemac Mechatronics IPO | The initial public offering is entirely an offer for sale of 80.43 lakh equity shares, with no fresh issue component.

    • Credent Global Finance raises Rs 30 crore capital through QIP for business growth

      Institutional investors participated in QIP, reinforcing investor confidence in Credent's evolving financial services platform and long-term growth strategy.

    • Accord Transformer, Mobilise App Lab IPOs attract robust demand but Kiaasa Retail sees muted response on final day

      Accord Transformer and Switchgear, Mobilise App Lab, and Kiaasa Retail will finalise IPO share allotment by February 26, while their shares will be available for trading on the bourses on March 2.

    • Cipla’s Yurpeak gains ground beyond metros as GLP‑1 market accelerates

      Strong uptake is visible across Mumbai, Bengaluru, Delhi, Chennai, Hyderabad, Indore and Pune, as well as smaller but fast‑growing centres such as Cannanore, Vijayawada, Aurangabad, Surat, Faizabad and Mangalore—locations where prescriber activation and distribution density are translating into early conversions.

    • OPINION | CSR at a Crossroads: Building systems, not just projects

      India’s growing CSR capital can create lasting national impact by shifting from short-term projects to systemic investments aligned with government priorities and strong leadership

    • TVS, Bajaj and Hero race ahead in electric two-wheeler market; Honda, Suzuki still to rev up

      TVS Motor Company, Bajaj Auto and Hero MotoCorp together command nearly 60% of the domestic E2W market, which has grown to approximately 1.23 lakh units a month

    • Omnitech Engineering raises Rs 175 crore via anchor book ahead of Rs 583-crore IPO

      Omnitech Engineering IPO | The company is raising Rs 418 crore by issuing fresh shares, while promoter Udaykumar Arunkumar Parekh will be selling shares worth Rs 165 crore via offer-for-sale.

    • Manilam Industries India IPO closes with 5.89 times subscription, listing likely scheduled on February 27

      Manilam Industries IPO | The company is raising Rs 40 crore via public issue of 57.9 lakh shares, which comprised of fresh issue of 46.98 lakh shares, and an offer-for-sale of 10.92 lakh shares.

    • Eris Lifesciences partners with Natco Pharma to launch semaglutide in India

      The collaboration follows Natco’s recent approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture generic semaglutide, setting up a planned launch in March 2026.

    • Reva Diamonds raises Rs 171 crore from 16 anchor investors, Rs 380-crore IPO to open for public on February 24

      PNGS Reva Diamond Jewellery IPO | The company has finalised allocation of 44.19 lakh equity shares to anchor investors at the upper price band.

    • Manilam Industries India IPO fully subscribed on day 2, offer closes on February 24

      Manilam Industries IPO | The Uttar Pradesh-based company is raising nearly Rs 40 crore via initial public offering of 57.9 lakh shares at the upper end of price band of Rs 65-69 per share.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347